SB
SAB Biotherapeutics, Inc.
SEC filingBiotechnology · Miami Beach, FL
Amount raised$175Msold at filing
Total offering$175M
Investors in the raise17count reported to the SEC
FiledAug 5, 2025first sale Jul 21, 2025
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Andrew MoinDirector
Jay SkylerDirector
Erick LuceraDirector
Samuel ReichExecutive Officer, Director
William PolvinoDirector
Katie ElliasDirector
Eddie SullivanExecutive Officer, Director
Jeffrey SpragensDirector
David LinkDirector
Scott GibersonDirector
Christine HamiltonDirector
Executive officers, directors and promoters as listed on the Form D.